Open original FDA record ↗Recall record
- FDA identifier
- Z-0805-2014
- Company in FDA record
- Sorin Group Italia S.r.l.
- FDA classification date
- Jan 22, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Sorin has voluntarily issued a notification to physicians related to the overestimation of the residual longevity displayed by its programmer (ORCHESTRA or ORCHESTRA PLUS) during a follow-up exam of patients implanted with a REPLY or ESPRIT pacemaker.
Source facts
- Action
- On Nov 20 and Nov 25, 2013, the Dear Doctor Letter was sent by certified mail to 1,310 physicians who are following 13,003 patients implanted with a REPLU or ESPRIT pacemakers in the US. Sorin provided the following recommendations to the physicians: You should consider checking the battery impedance of the last follow-up exam. In case the battery impedance is greater than or equal to 3.5k, a follow-up visit must be scheduled within a maximum of 6 months from the last follow-up visit. When pacemaker operation is checked by the simple application of a magnet, a magnet rate less than 95 min-1 should trigger a follow-up exam in the pacemaker centre. As a general rule, a maximum of 6 month follow-up interval when the battery impedance becomes greater than or equal to 3.5 k. This recommendation should also be followed subsequent to the installation of the new programmer software version.
- Initiated
- 2013-11-20
- Root cause
- Software design
- Terminated
- 2014-09-08
- Distribution
- Nationwide.
- Recall number
- Z-0805-2014
- Recall status
- Terminated
- CDRH record ID
- 124518
- FDA classified
- 2014-01-22
- Recall event number
- 67013